Home Overview Press Room Blog Publications For Students about us
Search

About Other Countries' Policies & Human Biotechnology


The United Kingdom

Countries differ widely in the types of human biotechnologies they regulate, the jurisdiction of authority, the nature of enforcement, and other particulars. One requirement for effective policy is a government agency responsible for licensing and monitoring research and commercial facilities that work with human embryos. Frequently cited models are Canada's Assisted Human Reproduction Act and the United Kingdom’s Human Fertilization and Embryology Authority (HFEA).

Many countries have considered prohibiting the most troubling applications: human reproductive cloning and inheritable genetic modification. To date, they are illegal in nearly 50 countries. Similar legislation is pending in other nations.



Surrogacy Boom in Mexico Brings Tales of Missing Money and Stolen Eggsby Jo TuckmanThe GuardianSeptember 25th, 2014Gestational mothers and new parents tell about the dark side of an industry that operates in a legal grey area.
South African Egg Donor Sent to India, Realizes Agency is Scamming Recipientsby Miranda WardWe Are Egg DonorsSeptember 22nd, 2014Martene is an active egg donor who has traveled internationally for her egg donations. While the recent cycles have been smooth and positive, her first cycle was a different story.
The Story of 10 Couples Who Fought Costa Rica’s Ban on in Vitro Fertilizationby Johanna TorresThe Costarican Times [Costa Rica]September 21st, 2014A new documentary tells the story of ten couples in Costa Rica who sued their government after it banned IVF.
Fertility Clinics: What the Law Saysby Laignee BarronThe Phnom Penh PostSeptember 20th, 2014Cambodia has its first IVF clinic, as well as several private and public fertility counselors, but no corresponding laws.
Interview: The Global Trade in Reproductionby Carmel ShalevBioEdgeSeptember 20th, 2014There have been too many cases of harm to children, and to women who agree to take part in reproductive collaborations for the benefit of others.
International Surrogacy, Global Consumerism, Harms to Women and Childrenby Carmel Shalev, Biopolitical Times guest contributorSeptember 15th, 2014Medical associations, nations, and the international community must intervene in the unregulated global market for surrogacy to protect, promote and sanction the human dignity and human rights of women and children.
Next-Generation Stem Cells Cleared for Human Trialby David CyranoskiNatureSeptember 10th, 2014A Japanese patient with a debilitating eye disease is about to become the first person to be treated with induced pluripotent stem cells.
Genetic Rights and Wrongsby EditorialNatureSeptember 9th, 2014Australia’s decision to uphold a patent on biological material is in danger of hampering the development of diagnostic tests.
Surrogate Targeted After Backing OutBangkok PostSeptember 9th, 2014A Thai surrogate mother who had second thoughts appealed for help from authorities after becoming the target of threats and intimidation by the surrogacy clinic and police working for them.
1 in 27 Babies Conceived Using IVF in 2012The Yomiuri ShimbunSeptember 9th, 2014There has been a sharp increase from 10 years ago in the number of babies in Japan conceived by in vitro fertilization, according to the Japan Society of Obstetrics and Gynecology.
Displaying 1-10 of 574  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760